Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 4 studies | 17% ± 1% | |
placental villous trophoblast | 3 studies | 69% ± 17% | |
epithelial cell | 3 studies | 26% ± 9% | |
oligodendrocyte | 3 studies | 22% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1683.39 | 245 / 245 | 100% | 23.98 | 500 / 502 |
lung | 100% | 1642.04 | 577 / 578 | 99% | 21.14 | 1149 / 1155 |
breast | 100% | 1657.90 | 459 / 459 | 99% | 22.87 | 1109 / 1118 |
esophagus | 100% | 1457.33 | 1445 / 1445 | 99% | 23.69 | 181 / 183 |
intestine | 100% | 1138.24 | 965 / 966 | 99% | 20.45 | 520 / 527 |
stomach | 100% | 1150.81 | 359 / 359 | 98% | 19.95 | 281 / 286 |
thymus | 100% | 1717.46 | 653 / 653 | 98% | 18.87 | 592 / 605 |
uterus | 100% | 2139.80 | 170 / 170 | 98% | 25.33 | 449 / 459 |
pancreas | 100% | 1362.23 | 328 / 328 | 98% | 14.79 | 174 / 178 |
bladder | 100% | 1396.86 | 21 / 21 | 96% | 17.52 | 486 / 504 |
kidney | 100% | 1068.54 | 89 / 89 | 92% | 11.85 | 830 / 901 |
liver | 100% | 1147.74 | 226 / 226 | 92% | 14.77 | 374 / 406 |
brain | 92% | 526.36 | 2442 / 2642 | 97% | 10.63 | 681 / 705 |
skin | 100% | 2301.49 | 1809 / 1809 | 89% | 13.49 | 419 / 472 |
adrenal gland | 100% | 4495.92 | 258 / 258 | 86% | 15.73 | 197 / 230 |
ovary | 100% | 2434.58 | 180 / 180 | 76% | 6.80 | 326 / 430 |
adipose | 100% | 1826.08 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1660.82 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1061.44 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 625.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 31.50 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.56 | 1 / 1 |
heart | 87% | 664.61 | 750 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 60% | 4.01 | 48 / 80 |
lymph node | 0% | 0 | 0 / 0 | 55% | 4.34 | 16 / 29 |
peripheral blood | 6% | 23.50 | 60 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0035064 | Molecular function | methylated histone binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | MORC4 |
Protein name | MORC family CW-type zinc finger 4 MORC family CW-type zinc finger protein 4 (Zinc finger CW-type coiled-coil domain protein 2) (Zinc finger CW-type domain protein 4) Alternative protein MORC4 |
Synonyms | ZCW4 ZCWCC2 |
Description | FUNCTION: Histone methylation reader which binds to non-methylated (H3K4me0), monomethylated (H3K4me1), dimethylated (H3K4me2) and trimethylated (H3K4me3) 'Lys-4' on histone H3 . The order of binding preference is H3K4me3 > H3K4me2 > H3K4me1 > H3K4me0 . . |
Accessions | Q8TE76 S4R3U3 L8E741 ENST00000604604.1 ENST00000355610.9 [Q8TE76-1] ENST00000255495.7 [Q8TE76-3] |